Safety and Efficacy Data on Radium-223 for the Palliative Treatment of mCRPC
Drs Armstrong and Manning review the safety and efficacy data from the ALSYMPCA trial of radium-223 in patients with mCRPC.
Source: onclive.com
Sabr Comet News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sabr Comet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sabr Comet Today - Breaking & Trending Today
Patient Profile: A 72-Year-Old Man with mCRPC and Multiple Bone Metastases
Radiation oncologist Matthew Manning, MD, shares the patient profile of a 72-year-old man with mCRPC receiving palliative treatment with radium-223.
Source: onclive.com
Patient Profile: A 78-Year-Old Man with mCRPC
Dr Andrew Armstrong presents a profile of a 78-year-old man with mCRPC with a single PSMA-avid bone metastasis and asks Dr Manning how he would treat the patient in question.
Source: onclive.com
Treatment Approaches for Patients with mCRPC and Bone-Only Disease Progression After Radiotherapy
Drs Manning and Armstrong discuss the best treatment approaches for a patient with mCRPC and disease progression in the bone after initial radiotherapy for metastatic disease.
Source: onclive.com
Approved Treatment Options for Patients with mCRPC
Medical oncologist Andrew Armstrong, MD, details the available treatment options for patients with mCRPC, and how recommendations vary by prior therapy and mutation status.
Source: onclive.com